In AQP4-NMO and -NMO spectrum disorders (NMOSDs), the implication of B cells in the pathophysiology of the disease is clearer than that in MS because of the presence of pathogenic, disease-characterizing, antibodies against AQP4. This evidence concerns the gene AQP4 and myeloid sarcoma.